GDMC secures $21 million to expand advanced genetic therapies
Genetic Design and Manufacturing Corporation (GDMC) has bagged $21 million in Series A funding to accelerate its next-gen advanced genetic therapies.
Source: biopharma-reporter.com
Stay updated with breaking news from Michael Koeris. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Genetic Design and Manufacturing Corporation (GDMC) has bagged $21 million in Series A funding to accelerate its next-gen advanced genetic therapies.
WI Harper Group and SEEDS Capital, the investment arm of Enterprise Singapore, as well as biotech-focused NSG Ventures also joined the round.